Business Context and Reporting Period
Company: Pyrophyte Acquisition Corp. II (PAII)
Filing Type: Form 8-K (Current Report)
Date of Report: July 18, 2025
Event: Consummation of Initial Public Offering (IPO) and entry into material definitive agreements.
Key Financial Metrics
| Metric | Value |
|---|---|
| Gross IPO Proceeds | $175,000,000 |
| Units Sold | 17,500,000 Units |
| Price Per Unit | $10.00 |
| Private Placement Proceeds | $5,050,000 |
| Private Placement Warrants Sold | 5,050,000 Warrants |
| Price Per Private Warrant | $1.00 |
| Funds in Trust Account | $175,000,000 (includes deferred commissions) |
| Warrant Exercise Price | $11.50 per share |
| Over-Allotment Option | Up to 2,625,000 additional Units (45-day option) |
Note: As this is an IPO filing, historical revenue, profit, cash flow, and margin data are not applicable. The filing does not provide specific debt figures beyond the deferred underwriting commission structure.
Material Changes and Agreements
- Capital Structure: The Company transitioned from a private entity to a public company listed on the New York Stock Exchange (NYSE) under symbols PAII.U, PAII, and PAII WS.
- Trust Account: $175,000,000 of net proceeds (including $7,875,000 in deferred underwriting commissions) was deposited into a U.S.-based trust account managed by Continental Stock Transfer & Trust Company.
- Private Placement: Simultaneously with the IPO, the Sponsor purchased 5,050,000 Private Placement Warrants for $5,050,000. These warrants are non-transferable until 30 days after the initial business combination.
- Corporate Governance: Three new independent directors (Matteo Pasquali, Per Hornung Pedersen, and Jamie Saxton) were appointed to the Board of Directors and assigned to various committees.
Outlook, Risks, and Contingencies
- Business Combination Deadline: The Company has 24 months from the closing of the IPO (July 18, 2025) to complete an initial business combination. Failure to do so will trigger a redemption of public shares.
- Redemption Rights: Public shareholders may redeem their shares for a pro-rata portion of the trust account if the Company fails to complete a business combination within the 24-month window or in connection with certain amendments to the Articles of Association.
- Trust Account Restrictions: Funds in the trust account generally cannot be released until the completion of a business combination, shareholder redemption, or specific tax/liquidation expense scenarios.
- Warrant Risk: Private Placement Warrants will be worthless if the Company does not complete an initial business combination.
Investor Verification Checklist
- Verify the final prospectus (dated July 16, 2025) for detailed terms of the Underwriting Agreement and Warrant Agreement.
- Confirm the exact amount of deferred underwriting commissions ($7,875,000) held within the trust account.
- Review the Amended and Restated Memorandum and Articles of Association for specific redemption thresholds and voting rights.
- Monitor the status of the 45-day over-allotment option for the purchase of up to 2,625,000 additional Units.
- Check for any subsequent filings regarding the selection of a target business combination within the 24-month window.